SUMMARY AND PERSPECTIVES

Even after more than 20 years of intensive investigation, the fundamental question of how HIV kills CD4⁺ T lymphocytes has defied a clear answer. Although a number of HIV proteins are cytotoxic in a variety of cellular systems, an open question remains as to which, if any, play a significant role in killing infected T cells in vivo.

REFERENCES

1. Tibbetts, M.D., Zheng, L., and Lenardo, M.J., The death effector domain protein family: regulators of cellular homeostasis, Nat. Immunol., 4, 404-409, 2003.

2. Budihardjo, I., Oliver, H., Lutter, M., Luo, X., and Wang, X., Biochemical pathways of caspase activation during apoptosis, Annu. Rev. Cell Dev. Biol., 15, 269-290, 1999.

3. Schultz, D.R. and Harrington, W.J., Jr., Apoptosis: programmed cell death at a molecular level, Semin. Arthritis Rheum., 32, 345-369, 2003.

4. Lockshin, R.A. and Zakeri, Z., Caspase-independent cell death? Oncogene, 23, 2766-2773, 2004.

5. Jaattela, M. and Tschopp, J., Caspase-independent cell death in T lymphocytes, Nat. Immunol., 4, 416-423, 2003.

6. Aggarwal, B.B., Signaling pathways of the TNF superfamily: a double-edged sword, Nat. Rev. Immunol., 3, 745-756, 2003.

7. Barnhart, B.C., Lee, J.C., Alappat, E.C., and Peter, M.E., The death effector domain protein family, Oncogene, 22, 8634-8644, 2003.

8. Droin, N.M. and Green, D.R., Role of Bcl-2 family members in immunity and disease, Biochim. Biophys. Acta, 1644, 179-188, 2004.

9. Petros, A.M., Olejniczak, E.T., and Fesik, S.W., Structural biology of the Bcl-2 family of proteins, Biochim.

10. Kucharczak, J., Simmons, M.J., Fan, Y., and Gelinas, C., To be, or not to be: NF-B is the answer—role of Rel/NF-B in the regulation of apoptosis, Oncogene, 22, 8961-8982, 2003.

11. Petit, F., Arnoult, D., Lelievre, J.D., Moutouh-de Parseval, L., Hance, A.J., Schneider, P., Corbeil, J., Ameisen, J.C., and Estaquier, J., Productive HIV-1 infection of primary CD4+ T cells induces mitochondrial membrane permeabilization leading to a caspase-independent cell death, J. Biol. Chem., 277, 1477-1487, 2002.

12. Noraz, N., Gozlan, J., Corbeil, J., Brunner, T., and Spector, S.A., HIV-induced apoptosis of activated primary CD4+ T lymphocytes is not mediated by Fas-Fas ligand, AIDS, 11, 1671-1680, 1997.

13. Herbein, G., Van Lint, C., Lovett, J.L., and Verdin, E., Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes, J. Virol., 72, 660-670, 1998.

14. Gandhi, R.T., Chen, B.K., Straus, S.E., Dale, J.K., Lenardo, M.J., and Baltimore, D., HIV-1 directly kills CD4+ T cells by a Fas-independent mechanism, J. Exp. Med., 187, 1113-1122, 1998.

15. Terai, C., Kornbluth, R.S., Pauza, C.D., Richman, D.D., and Carson, D.A., Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1, J. Clin. Invest., 87, 1710-1715,

1991.

16. Laurent-Crawford, A.G., Krust, B., Muller, S., Riviere, Y., Rey-Cuille, M.A., Bechet, J.M., Montagnier,

L., and Hovanessian, A.G., The cytopathic effect of HIV is associated with apoptosis, Virology, 185, 829-839, 1991.

17. Genini, D., Sheeter, D., Rought, S., Zaunders, J.J., Susin, S.A., Kroemer, G., Richman, D.D., Carson, D.A., Corbeil, J., and Leoni, L.M., HIV induces lymphocyte apoptosis by a p53-initiated, mitochon- drial-mediated mechanism, FASEB J., 15, 5-6, 2001.

18. Lenardo, M.J., Angleman, S.B., Bounkeua, V., Dimas, J., Duvall, M.G., Graubard, M.B., Hornung, F., Selkirk, M.C., Speirs, C.K., Trageser, C., Orenstein, J.O., and Bolton, D.L., Cytopathic killing of peripheral blood CD4(+) T lymphocytes by human immunodeficiency virus type 1 appears necrotic rather than apoptotic and does not require Env, J.

19. Bolton, D.L., Hahn, B.I., Park, E.A., Lehnhoff, L.L., Hornung, F., and Lenardo, M.J., Death of CD4(+) T-cell lines caused by human immunodeficiency virus type 1 does not depend on caspases or apoptosis, J. Virol., 76, 5094-5107, 2002.

20. Kolesnitchenko, V., King, L., Riva, A., Tani, Y., Korsmeyer, S.J., and Cohen, D.I., A major human immunodeficiency virus type 1-initiated killing pathway distinct from apoptosis, J. Virol., 71, 9753-9763, 1997.

21. Kolesnitchenko, V., Wahl, L.M., Tian, H., Sunila, I., Tani, Y., Hartmann, D.P., Cossman, J., Raffeld,

M., Orenstein, J., Samuelson, L.E., Human immunodeficiency virus 1 envelope-initiated G2-phase programmed cell death, Proc. Natl. Acad. Sci. U.S.A., 92, 11889-11893, 1995.

22. McKeating, J.A., McKnight, A., and Moore, J.P., Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization, J. Virol., 65, 852-860, 1991.

23. Schneider, J., Kaaden, O., Copeland, T.D., Oroszlan, S., and Hunsmann, G., Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus, J. Gen. Virol., 67 (Pt. 11), 2533-2538, 1986.

24. Sodroski, J., Goh, W.C., Rosen, C., Campbell, K., and Haseltine, W.A., Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity, Nature, 322, 470-474, 1986.

25. Lifson, J.D., Reyes, G.R., McGrath, M.S., Stein, B.S., and Engleman, E.G, AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen, Science, 232, 1123-1127, 1986.

26. Buonocore, L. and Rose, J.K., Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum, Nature, 345, 625-628, 1990.

27. Crise, B., Buonocore, L., and Rose, J.K., CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor, J. Virol., 64, 5585-5593, 1990.

28. Garcia, J.V. and Miller, A.D., Serine phosphorylation-independent downregulation of cell-surface CD4 by Nef, Nature, 350, 508-511, 1991.

29. Aiken, C., Konner, J., Landau, N.R., Lenburg, M.E., and Trono, D., Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain, Cell, 76, 853-864, 1994.

30. Willey, R.L., Maldarelli, F., Martin, M.A., and Strebel, K., Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes, J. Virol., 66, 226-234,

1992.

31. Willey, R.L., Maldarelli, F., Martin, M.A., and Strebel, K., Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4, J. Virol., 66, 7193-7200, 1992.

32. Somasundaran, M. and Robinson, H.L., A major mechanism of human immunodeficiency virus- induced cell killing does not involve cell fusion, J. Virol., 61, 3114-3119, 1987.

33. Dargent, J.L., Lespagnard, L., Kornreich, A., Hermans, P., Clumeck, N., and Verhest, A., HIV- associated multinucleated giant cells in lymphoid tissue of the Waldeyer's ring: a detailed study, Mod. Pathol., 13, 1293-1299, 2000.

34. Lewin-Smith, M., Wahl, S.M., and Orenstein, J.M., Human immunodeficiency virus-rich multi­nucleated giant cells in the colon: a case report with transmission electron microscopy, immuno­histochemistry, and in situ hybridization, Mod. Pathol., 12, 75-81, 1999.

35. Li, S.L., Kaaya, E.E., Feichtinger, H., Putkonen, P., Parravicini, C., Bottiger, D., Biberfeld, G., and Biberfeld, P., Monocyte/macrophage giant cell disease in SΓV-infected cynomolgus monkeys, Res. Virol., 142, 173-182, 1991.

36. Maier, H., Budka, H., Lassmann, H., and Pohl, P., Vacuolar myelopathy with multinucleated giant cells in the acquired immune deficiency syndrome (AIDS). Light and electron microscopic distribution of human immunodeficiency virus (HIV) antigens, Acta Neuropathol. (Berl.), 78, 497-503, 1989.

37. Ryzhova, E.V., Crino, P., Shawver, L., Westmoreland, S.V., Lackner, A.A., and Gonzalez-Scarano, F., Simian immunodeficiency virus encephalitis: analysis of envelope sequences from individual brain multinucleated giant cells and tissue samples, Virology, 297, 57-67, 2002.

38. Stevenson, M., Haggerty, S., Lamonica, C., Mann, A.M., Meier, C., and Wasiak, A., Cloning and characterization of human immunodeficiency virus type 1 variants diminished in the ability to induce syncytium-independent cytolysis, J. Virol., 64, 3792-3803, 1990.

39. Cao, J., Vasir, B., and Sodroski, J.G., Changes in the cytopathic effects of human immunodeficiency virus type 1 associated with a single amino acid alteration in the ectodomain of the gp41 trans­membrane glycoprotein, J. Virol., 68, 4662-4668, 1994.

40. Kowalski, M., Bergeron, L., Dorfman, T., Haseltine, W., and Sodroski, J., Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein, J. Virol., 65, 281-291, 1991.

41. Sasaki, M., Uchiyama, J., Ishikawa, H., Matsushita, S., Kimura, G., Nomoto, K., and Koga, Y., Induction of apoptosis by calmodulin-dependent intracellular Ca2+ elevation in CD4+ cells expressing gp 160 of HIV, Virology, 224, 18-24, 1996.

42. Lu, Y.Y., Koga, Y., Tanaka, K., Sasaki, M., Kimura, G., and Nomoto, K., Apoptosis induced in CD4+ cells expressing gp160 of human immunodeficiency virus type 1, J. Virol., 68, 390-399, 1994.

43. Koga, Y., Nakamura, K., Sasaki, M., Kimura, G., and Nomoto, K., The difference in gp160 and gp120 of HIV type 1 in the induction of CD4 downregulation preceding single-cell killing, Virology, 201, 137-141, 1994.

44. Koga, Y., Sasaki, M., Nakamura, K., Kimura, G., and Nomoto, K., Intracellular distribution of the envelope glycoprotein of human immunodeficiency virus and its role in the production of cytopathic effect in CD4+ and CD4 human cell lines, J. Virol., 64, 4661-4671, 1990.

45. Koga, Y., Sasaki, M., Yoshida, H., Oh-Tsu, M., Kimura, G., and Nomoto, K., Disturbance of nuclear transport of proteins in CD4+ cells expressing gp160 of human immunodeficiency virus, J. Virol., 65, 5609-5612, 1991.

46. Bergeron, L. and Sodroski, J., Dissociation of unintegrated viral DNA accumulation from single­cell lysis induced by human immunodeficiency virus type 1, J.

47. LaBonte, J.A., Madani, N., and Sodroski, J., Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression, J. Virol., 77, 6645-6659, 2003.

48. LaBonte, J.A., Patel, T., Hofmann, W., and Sodroski, J., Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells, J. Virol., 74, 10690-10698, 2000.

49. Park, I.W., Kondo, E., Bergeron, L., Park, J., and Sodroski, J., Effects of human immunodeficiency virus type 1 infection on programmed cell death in the presence or absence of Bcl-2, J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 12, 321-328, 1996.

50. Corbeil, J., Tremblay, M., and Richman, D.D., HIV-induced apoptosis requires the CD4 receptor cytoplasmic tail and is accelerated by interaction of CD4 with p56lck, J. Exp. Med., 183, 39-48, 1996.

51. Corbeil, J. and Richman, D.D., Productive infection and subsequent interaction of CD4-gp120 at the cellular membrane is required for HIV-induced apoptosis of CD4+ T cells, J. Gen. Virol., 76 (Pt. 3), 681-690, 1995.

52. Moutouh, L., Estaquier, J., Richman, D.D., and Corbeil, J., Molecular and cellular analysis of human immunodeficiency virus-induced apoptosis in lymphoblastoid T-cell-line-expressing wild-type and mutated CD4 receptors, J. Virol., 72, 8061-8072, 1998.

53. Akari, H., Bour, S., Kao, S., Adachi, A., and Strebel, K., The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor B-dependent expression of antiapoptotic factors, J. Exp. Med., 194, 1299-1311, 2001.

54. Mustafa, F. and Robinson, H.L., Context-dependent role of human immunodeficiency virus type 1 auxiliary genes in the establishment of chronic virus producers, J. Virol., 67, 6909-6915, 1993.

55. Rogel, M.E., Wu, L.I., and Emerman, M., The human immunodeficiency virus type 1 Vpr gene prevents cell proliferation during chronic infection, J. Virol., 69, 882-888, 1995.

56. Somasundaran, M., Sharkey, M., Brichacek, B., Luzuriaga, K., Emerman, M., Sullivan, J.L., and Stevenson, M., Evidence for a cytopathogenicity determinant in HIV-1 Vpr, Proc. Natl. Acad. Sci. U.S.A., 99, 9503-9508, 2002.

57. Lum, J.J., Cohen, O.J., Nie, Z., Weaver, J.G., Gomez, T.S., Yao, X. J., Lynch, D., Pilon, A.A., Hawley,

N., Kim, J.E., Chen, Z., Montpetit, M., Sanchez-Dardon, J., Cohen, E.A., and Badley, A.D., Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis, J. Clin. Invest., 111, 1547-1554, 2003.

58. Macreadie, I.G., Castelli, L.A., Hewish, D.R., Kirkpatrick, A., Ward, A.C., and Azad, A.A., A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S∕F)RIG amino acid motifs causes cell growth arrest and structural defects, Proc. Natl. Acad. Sci. U.S.A., 92, 2770-2774, 1995.

59. Yasuda, J., Miyao, T., Kamata, M., Aida, Y., and Iwakura, Y., T cell apoptosis causes peripheral T cell depletion in mice transgenic for the HIV-1 Vpr gene, Virology, 285, 181-192, 2001.

60. Stewart, S.A., Poon, B., Jowett, J.B., and Chen, I.S., Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest, J. Virol., 71, 5579-5592, 1997.

61. Stewart, S.A., Poon, B., Song, J.Y., and Chen, I.S., Human immunodeficiency virus type 1 Vpr induces apoptosis through caspase activation, J. Virol., 74, 3105-3111, 2000.

62. Muthumani, K., Hwang, D.S., Desai, B.M., Zhang, D., Dayes, N., Green, D.R., and Weiner, D.B., HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells, J. Biol. Chem., 277, 37820-37831, 2002.

63. Muthumani, K., Zhang, D., Hwang, D.S., Kudchodkar, S., Dayes, N.S., Desai, B.M., Malik, A.S., Yang, J.S., Chattergoon, M.A., Maguire, H.C., Jr., and Weiner, D.B., Adenovirus encoding HIV-1 Vpr activates caspase 9 and induces apoptotic cell death in both p53 positive and negative human tumor cell lines, Oncogene, 21, 4613-4625, 2002.

64. Conti, L., Matarrese, P., Varano, B., Gauzzi, M.C., Sato, A., Malorni, W., Belardelli, F., and Gessani, S., Dual role of the HIV-1 Vpr protein in the modulation of the apoptotic response of T cells, J. Immunol., 165, 3293-3300, 2000.

65. Conti, L., Rainaldi, G., Matarrese, P., Varano, B., Rivabene, R., Columba, S., Sato, A., Belardelli, F., Malorni, W., and Gessani, S., The HIV-1 Vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: possible implications for the pathogenesis of AIDS, J. Exp. Med., 187, 403-413, 1998.

66. Ayyavoo, V., Mahboubi, A., Mahalingam, S., Ramalingam, R., Kudchodkar, S., Williams, W.V., Green,

D. R., and Weiner, D.B., HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor B, Nat. Med., 3, 1117-1123, 1997.

67. Levy, D.N., Refaeli, Y., MacGregor, R.R., and Weiner, D.B., Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1, Proc. Natl. Acad. Sci. U.S.A., 91, 10873-10877, 1994.

68. Sherman, M.P., Schubert, U., Williams, S.A., de Noronha, C.M., Kreisberg, J.F., Henklein, P., and Greene, W.C., HIV-1 Vpr displays natural protein-transducing properties: implications for viral patho­genesis, Virology, 302, 95-105, 2002.

69. Stewart, S.A., Poon, B., Jowett, J.B., Xie, Y., and Chen, I.S., Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells, Proc. Natl. Acad. Sci. U.S.A., 96, 12039-12043, 1999.

70. Yao, X.J., Mouland, A.J., Subbramanian, R.A., Forget, J., Rougeau, N., Bergeron, D., and Cohen,

E. A., Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells, J. Virol., 72, 4686-4693, 1998.

71. Nishizawa, M., Kamata, M., Mojin, T., Nakai, Y., and Aida, Y., Induction of apoptosis by the Vpr protein of human immunodeficiency virus type 1 occurs independently of G(2) arrest of the cell cycle, Virology, 276, 16-26, 2000.

72. Jacotot, E., Ravagnan, L., Loeffler, M., Ferri, K.F., Vieira, H.L., Zamzami, N., Costantini, P., Druil- lennec, S., Hoebeke, J., Briand, J.P., Irinopoulou, T., Daugas, E., Susin, S.A., Cointe, D., Xie, Z.H., Reed, J.C., Roques, B.P., and Kroemer, G., The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore, J. Exp. Med., 191, 33-46, 2000.

73. Jacotot, E., Ferri, K.F., El Hamel, C., Brenner, C., Druillennec, S., Hoebeke, J., Rustin, P., Metivier, D., Lenoir, C., Geuskens, M., Vieira, H.L., Loeffler, M., Belzacq, A.S., Briand, J.P., Zamzami, N., Edelman, L., Xie, Z.H., Reed, J.C., Roques, B.P., and Kroemer, G., Control of mitochondrial mem­brane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2, J. Exp. Med., 193, 509-519, 2001.

74. Roumier, T., Vieira, H.L., Castedo, M., Ferri, K.F., Boya, P., Andreau, K., Druillennec, S., Joza, N., Penninger, J.M., Roques, B., and Kroemer, G., The C-terminal moiety of HIV-1 Vpr induces cell death via a caspase-independent mitochondrial pathway, Cell Death Differ., 9, 1212-1219, 2002.

75. Bartz, S.R. and Emerman, M., Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8, J. Virol., 73, 1956-1963, 1999.

76. Ghosh, S. and Karin, M., Missing pieces in the NF-B puzzle, Cell, 109 (Suppl.), S81-S96, 2002.

77. Suzuki, H., Chiba, T., Kobayashi, M., Takeuchi, M., Suzuki, T., Ichiyama, A., Ikenoue, T., Omata, M., Furuichi, K., and Tanaka, K., IB ubiquitination is catalyzed by an SCF-like complex containing Skp1, cullin-1, and two F-box∕WD40-repeat proteins, TrCP1 and TrCP2, Biochem. Biophys. Res. Commun., 256, 127-132, 1999.

78. Spencer, E., Jiang, J., and Chen, Z.J., Signal-induced ubiquitination of IB by the F-box protein Slimb∕-TrCP, Genes Dev., 13, 284-294, 1999.

79. Wu, C. and Ghosh, S., -TrCP mediates the signal-induced ubiquitination of IB, J. Biol. Chem., 274, 29591-29594, 1999.

80. Hatakeyama, S., Kitagawa, M., Nakayama, K., Shirane, M., Matsumoto, M., Hattori, K., Higashi, H., Nakano, H., Okumura, K., Onoe, K., and Good, R.A., Ubiquitin-dependent degradation of IB is mediated by a ubiquitin ligase Skp1∕Cul 1/F-box protein FWD1, Proc. Natl. Acad. Sci. U.S.A., 96, 3859-3863, 1999.

81. Kroll, M., Margottin, F., Kohl, A., Renard, P., Durand, H., Concordet, J.P., Bachelerie, F., Arenzana- Seisdedos, F., and Benarous, R., Inducible degradation of IB by the proteasome requires interaction with the F-box protein h-TrCP, J. Biol. Chem., 274, 7941-7945, 1999.

82. Yaron, A., Hatzubai, A., Davis, M., Lavon, I., Amit, S., Manning, A.M., Andersen, J.S., Mann, M., Mercurio, F., and Ben-Neriah, Y., Identification of the receptor component of the IB-ubiquitin ligase, Nature, 396, 590-594, 1998.

83. Margottin, F., Bour, S.P., Durand, H., Selig, L., Benichou, S., Richard, V., Thomas, D., Strebel, K., and Benarous, R., A novel human WD protein, h-TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif, Mol. Cell, 1, 565-574, 1998.

84. Bour, S., Perrin, C., Akari, H., and Strebel, K., The human immunodeficiency virus type 1 Vpu protein inhibits NF-B activation by interfering with TrCP-mediated degradation of IB, J. Biol. Chem., 276, 15920-15928, 2001.

85. Besnard-Guerin, C., Belaidouni, N., Lassot, I., Segeral, E., Jobart, A., Marchal, C., and Benarous, R., HIV-1 Vpu sequesters -transducin repeat-containing protein (TrCP) in the cytoplasm and provokes the accumulation of -catenin and other SCFTrCP substrates, J. Biol. Chem., 279, 788-795, 2004.

86. Krausslich, H.G., Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity, Proc. Natl. Acad. Sci. U.S.A., 88, 3213-3217, 1991.

87. Blanco, R., Carrasco, L., and Ventoso, I., Cell killing by HIV-1 protease, J. Biol. Chem., 278, 1086-1093, 2003.

88. Buttner, J., Dornmair, K., and Schramm, H.J., Screening of inhibitors of HIV-1 protease using an Escherichia coli cell assay, Biochem. Biophys. Res. Commun., 233, 36-38, 1997.

89. Schlick, P. and Skern, T., Eukaryotic initiation factor 4GI is a poor substrate for HIV-1 proteinase, FEBS Lett., 529, 337-340, 2002.

90. Alvarez, E., Menendez-Arias, L., and Carrasco, L., The eukaryotic translation initiation factor 4GI is cleaved by different retroviral proteases, J. Virol., 77, 12392-12400, 2003.

91. Ventoso, I., Blanco, R., Perales, C., and Carrasco, L., HIV-1 protease cleaves eukaryotic initiation factor 4G and inhibits cap-dependent translation, Proc. Natl. Acad. Sci. U.S.A., 98, 12966-12971, 2001.

92. Shoeman, R.L., Huttermann, C., Hartig, R., and Traub, P., Amino-terminal polypeptides of vimentin are responsible for the changes in nuclear architecture associated with human immunodeficiency virus type 1 protease activity in tissue culture cells, Mol. Biol. Cell, 12, 143-154, 2001.

93. Honer, B., Shoeman, R.L., and Traub, P., Human immunodeficiency virus type 1 protease micro­injected into cultured human skin fibroblasts cleaves vimentin and affects cytoskeletal and nuclear architecture, J. Cell Sci., 100, 799-807, 1991.

94. Shoeman, R.L., Honer, B., Stoller, T.J., Kesselmeier, C., Miedel, M.C., Traub, P., and Graves, M.C., Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein, Proc. Natl. Acad. Sci. U.S.A., 87, 6336-6340, 1990.

95. Riviere, Y., Blank, V., Kourilsky, P., and Israel, A., Processing of the precursor of NF-B by the HIV- 1 protease during acute infection, Nature, 350, 625-626, 1991.

96. Tomasselli, A.G., Hui, J.O., Adams, L., Chosay, J., Lowery, D., Greenberg, B., Yem, A., Deibel, M.R., Zurcher-Neely, H., and Heinrikson, R.L., Actin, troponin C, Alzheimer amyloid precursor protein and pro-interleukin 1 as substrates of the protease from human immunodeficiency virus, J. Biol. Chem., 266, 14548-14553, 1991.

97. Strack, P.R., Frey, M.W., Rizzo, C.J., Cordova, B., George, H.J., Meade, R., Ho, S.P., Corman, J., Tritch, R., and Korant, B.D., Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2, Proc. Natl. Acad. Sci. U.S.A., 93, 9571-9576, 1996.

98. Nie, Z., Phenix, B.N., Lum, J.J., Alam, A., Lynch, D.H., Beckett, B., Krammer, P.H., Sekaly, R.P., and Badley, A.D., HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation, Cell Death Differ., 9, 1172-1184, 2002.

99. Konvalinka, J., Litterst, M.A., Welker, R., Kottler, H., Rippmann, F., Heuser, A.M., and Krausslich, H.G., An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity, J. Virol., 69, 7180-7186, 1995.

100. Ensoli, B., Buonaguro, L., Barillari, G., Fiorelli, V., Gendelman, R., Morgan, R.A., Wingfield, P., and Gallo, R.C., Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation, J. Virol., 67, 277-287, 1993.

101. Frankel, A.D. and Pabo, C.O., Cellular uptake of the Tat protein from human immunodeficiency virus, Cell, 55, 1189-1193, 1988.

102. Mann, D.A. and Frankel, A.D., Endocytosis and targeting of exogenous HIV-1 Tat protein, EMBO J., 10, 1733-1739, 1991.

103. Helland, D.E., Welles, J.L., Caputo, A., and Haseltine, W.A., Transcellular transactivation by the human immunodeficiency virus type 1 Tat protein, J. Virol., 65, 4547-4549, 1991.

104. Wei, P., Garber, M.E., Fang, S.M., Fischer, W.H., and Jones, K.A., A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA, Cell, 92, 451-462, 1998.

105. Peng, J., Marshall, N.F., and Price, D.H., Identification of a cyclin subunit required for the function of Drosophila P-TEFb, J. Biol. Chem., 273, 13855-13860, 1998.

106. Mancebo, H.S., Lee, G., Flygare, J., Tomassini, J., Luu, P., Zhu, Y., Peng, J., Blau, C., Hazuda, D., Price, D., and Flores, O., P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro, Genes Dev., 11, 2633-2644, 1997.

107. Marzio, G., Tyagi, M., Gutierrez, M.I., and Giacca, M., HIV-1 Tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter, Proc. Natl. Acad. Sci. U.S.A., 95, 13519-13524, 1998.

108. Benkirane, M., Chun, R.F., Xiao, H., Ogryzko, V.V., Howard, B.H., Nakatani, Y., and Jeang, K.T., Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat, J. Biol. Chem., 273, 24898-24905, 1998.

109. Hottiger, M.O. and Nabel, G.J., Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein, J. Vιrol., 72, 8252-8256, 1998.

110. Yang, Y., Dong, B., Mittelstadt, P.R., Xiao, H., and Ashwell, J.D., HIV Tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter, J. Biol. Chem., 277, 19482-19487, 2002.

111. Li, C.J., Friedman, D.J., Wang, C., Metelev, V., and Pardee, A.B., Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein, Science, 268, 429-431, 1995.

112. Ehret, A., Westendorp, M.O., Herr, I., Debatin, K.M., Heeney, J.L., Frank, R., and Krammer, P.H., Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosis, J. Virol., 70, 6502-6507, 1996.

113. Westendorp, M.O., Frank, R., Ochsenbauer, C., Stricker, K., Dhein, J., Walczak, H., Debatin, K.M., and Krammer, P.H., Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120, Nature, 375, 497-500, 1995.

114. McCloskey, T.W., Ott, M., Tribble, E., Khan, S. A., Teichberg, S., Paul, M.O., Pahwa, S., Verdin, E., and Chirmule, N., Dual role of HIV Tat in regulation of apoptosis in T cells, J. Immunol., 158, 1014-1019, 1997.

115. Katsikis, P.D., Garcia-Ojeda, M.E., Torres-Roca, J.F., Greenwald, D.R., and Herzenberg, L.A., HIV type 1 Tat protein enhances activation—but not Fas (CD95)-induced peripheral blood T cell apoptosis in healthy individuals, Int. Immunol., 9, 835-841, 1997.

116. Sastry, K.J., Marin, M.C., Nehete, P.N., McConnell, K., el-Naggar, A.K., and McDonnell, T.J., Expression of human immunodeficiency virus type I Tat results in down-regulation of Bcl-2 and induction of apoptosis in hematopoietic cells, Oncogene, 13, 487-493, 1996.

117. Li-Weber, M., Laur, O., Dern, K., and Krammer, P.H., T cell activation-induced and HIV Tat-enhanced CD95(APO-1∕Fas) ligand transcription involves NF-B, Eur. J. Immunol., 30, 661-670, 2000.

118. Yagi, T., Sugimoto, A., Tanaka, M., Nagata, S., Yasuda, S., Yagita, H., Kuriyama, T., Takemori, T., and Tsunetsugu-Yokota, Y., Fas/FasL interaction is not involved in apoptosis of activated CD4+ T cells upon HIV-1 infection in vitro, J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 18, 307-315, 1998.

119. Westendorp, M.O., Shatrov, V.A., Schulze-Osthoff, K., Frank, R., Kraft, M., Los, M., Krammer, P.H., Droge, W., and Lehmann, V., HIV-1 Tat potentiates TNF-induced NF-B activation and cytotoxicity by altering the cellular redox state, EMBO J., 14, 546-554, 1995.

120. Zauli, G., Gibellini, D., Caputo, A., Bassini, A., Negrini, M., Monne, M., Mazzoni, M., and Capitani, S., The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells, Blood, 86, 3823-3834, 1995.

121. Wang, Z., Morris, G.F., Reed, J.C., Kelly, G.D., and Morris, C.B., Activation of Bcl-2 promoter- directed gene expression by the human immunodeficiency virus type-1 Tat protein, Virology, 257, 502-510, 1999.

122. Corallini, A., Sampaolesi, R., Possati, L., Merlin, M., Bagnarelli, P., Piola, C., Fabris, M., Menegatti, M.A., Talevi, S., Gibellini, D., Rocchetti, R., Caputo, A., and Barbanti-Brodano, G., Inhibition of HIV-1 Tat activity correlates with down-regulation of Bcl-2 and results in reduction of angiogenesis and oncogenicity, Virology, 299, 1-7, 2002.

123. Macho, A., Calzado, M.A., Jimenez-Reina, L., Ceballos, E., Leon, J., and Munoz, E., Susceptibility of HIV-1-TAT transfected cells to undergo apoptosis. Biochemical mechanisms, Oncogene, 18, 7543-7551, 1999.

124. Chen, D., Wang, M., Zhou, S., and Zhou, Q., HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim, EMBO J., 21, 6801-6810, 2002.

125. Gibellini, D., Re, M.C., Ponti, C., Celeghini, C., Melloni, E., La Placa, M., and Zauli, G., Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells, Br. J. Haematol., 112, 663-670, 2001.

126. Gibellini, D., Re, M.C., Ponti, C., Maldini, C., Celeghini, C., Cappellini, A., La Placa, M., and Zauli, G., HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand, Cell. Immunol., 207, 89-99, 2001.

127. Gibellini, D., Caputo, A., Celeghini, C., Bassini, A., La Placa, M., Capitani, S., and Zauli, G., Tat- expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection, Br. J. Haematol., 89, 24-33, 1995.

128. Wang, L., Klimpel, G.R., Planas, J.M., Li, H., and Cloyd, M.W., Apoptotic killing of CD4+ T lymphocytes in HIV-1-infected PHA-stimulated PBL cultures is mediated by CD8+ LAK cells, Virology, 241, 169-180, 1998.

129. Finkel, T.H., Tudor-Williams, G., Banda, N.K., Cotton, M.F., Curiel, T., Monks, C., Baba, T.W., Ruprecht, R.M., and Kupfer, A., Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes, Nat. Med., 1, 129-134, 1995.

130. Dockrell, D.H., The multiple roles of Fas ligand in the pathogenesis of infectious diseases, Clin. Microbiol. Infect., 9, 766-779, 2003.

131. Kayagaki, N., Kawasaki, A., Ebata, T., Ohmoto, H., Ikeda, S., Inoue, S., Yoshino, K., Okumura, K., and Yagita, H., Metalloproteinase-mediated release of human Fas ligand, J. Exp. Med., 182, 1777-1783, 1995.

132. Mitra, D., Steiner, M., Lynch, D.H., Staiano-Coico, L., and Laurence, J., HIV-1 upregulates Fas ligand expression in CD4+ T cells in vitro and in vivo: association with Fas-mediated apoptosis and modu­lation by aurintricarboxylic acid, Immunology, 87, 581-585, 1996.

133. Hosaka, N., Oyaizu, N., Kaplan, M.H., Yagita, H., and Pahwa, S., Membrane and soluble forms of Fas (CD95) and Fas ligand in peripheral blood mononuclear cells and in plasma from human immu­nodeficiency virus-infected persons, J. Infect. Dis., 178, 1030-1039, 1998.

134. Katsikis, P.D., Wunderlich, E.S., Smith, C.A., and Herzenberg, L.A., Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals, J. Exp. Med., 181, 2029-2036, 1995.

135. Yang, Y., Liu, Z.H., Ware, C.F., and Ashwell, J.D., A cysteine protease inhibitor prevents activation- induced T-cell apoptosis and death of peripheral blood cells from human immunodeficiency virus- infected individuals by inhibiting upregulation of Fas ligand, Blood, 89, 550-557, 1997.

136. Baumler, C.B., Bohler, T., Herr, I., Benner, A., Krammer, P.H., and Debatin, K.M., Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children, Blood, 88, 1741-1746, 1996.

137. Debatin, K.M., Fahrig-Faissner, A., Enenkel-Stoodt, S., Kreuz, W., Benner, A., and Krammer, P.H., High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children, Blood, 83, 3101-3103, 1994.

138. Badley, A.D., McElhinny, J.A., Leibson, PJ., Lynch, D.H., Alderson, M.R., and Paya, C.V., Upregu­lation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes, J. Virol., 70, 199-206, 1996.

139. Dockrell, D.H., Badley, A.D., Villacian, J.S., Heppelmann, C.J., Algeciras, A., Ziesmer, S., Yagita, H., Lynch, D.H., Roche, P.C., Leibson, PJ., and Paya, C.V., The expression of Fas ligand by mac­rophages and its upregulation by human immunodeficiency virus infection, J. Clin. Invest., 101, 2394-2405, 1998.

140. Cohen, S.S., Li, C., Ding, L., Cao, Y., Pardee, A.B., Shevach, E.M., and Cohen, D.I., Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge, Proc. Natl. Acad. Sci. U.S.A., 96, 10842-10847, 1999.

141. Oyaizu, N., Adachi, Y., Hashimoto, F., McCloskey, T.W., Hosaka, N., Kayagaki, N., Yagita, H., and Pahwa, S., Monocytes express Fas ligand upon CD4 cross-linking and induce CD4+ T cells apoptosis: a possible mechanism of bystander cell death in HIV infection, J. Immunol., 158, 2456-2463, 1997.

142. Han, X., Becker, K., Degen, H.J., Jablonowski, H., and Strohmeyer, G., Synergistic stimulatory effects of tumour necrosis factor and interferon on replication of human immunodeficiency virus type 1 and on apoptosis of HIV-1-infected host cells, Eur. J. Clin. Invest., 26, 286-292, 1996.

143. Badley, A.D., Dockrell, D., Simpson, M., Schut, R., Lynch, D.H., Leibson, P., and Paya, C.V., Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor, J. Exp. Med., 185, 55-64, 1997.

144. Jeremias, I., Herr, I., Boehler, T., and Debatin, K.M., TRAIL/Apo-2-ligand-induced apoptosis in human T cells, Eur. J. Immunol., 28, 143-152, 1998.

145. Katsikis, P.D., Garcia-Ojeda, M.E., Torres-Roca, J.F., Tijoe, I.M., Smith, C.A., and Herzenberg, L.A., Interleukin-1 converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection, J. Exp. Med., 186, 1365-1372, 1997.

146. Fujii, Y., Otake, K., Tashiro, M., and Adachi, A., Soluble Nef antigen of HIV-1 is cytotoxic for human CD4+ T cells, FEBS Lett., 393, 93-96, 1996.

147. Okada, H., Takei, R., and Tashiro, M., HIV-1 Nef protein-induced apoptotic cytolysis of a broad spectrum of uninfected human blood cells independently of CD95(Fas), FEBS Lett., 414, 603-606,

1997.

148. Okada, H., Takei, R., and Tashiro, M., Nef protein of HIV-1 induces apoptotic cytolysis of murine lymphoid cells independently of CD95 (Fas) and its suppression by serine/threonine protein kinase inhibitors, FEBS Lett., 417, 61-64, 1997.

149. Okada, H., Takei, R., and Tashiro, M., Inhibition of HIV-1 Nef-induced apoptosis of uninfected human blood cells by serine/threonine protein kinase inhibitors, fasudil hydrochloride and M3, FEBS Lett., 422, 363-367, 1998.

150. James, C.O., Huang, M.B., Khan, M., Garcia-Barrio, M., Powell, M.D., and Bond, V.C., Extracellular Nef protein targets CD4+ T cells for apoptosis by interacting with CXCR4 surface receptors, J. Virol., 78, 3099-3109, 2004.

151. Manninen, A., Hiipakka, M., Vihinen, M., Lu, W., Mayer, B.J., and Saksela, K., SH3-Domain binding function of HIV-1 Nef is required for association with a PAK-related kinase, Virology, 250, 273-282,

1998.

152. Geleziunas, R., Xu, W., Takeda, K., Ichijo, H., and Greene, W.C., HIV-1 Nef inhibits ASK1-dependent death signaling providing a potential mechanism for protecting the infected host cell, Nature, 410, 834-838, 2001.

153. Hodge, S., Novembre, F.J., Whetter, L., Gelbard, H.A., and Dewhurst, S., Induction of Fas ligand expression by an acutely lethal simian immunodeficiency virus, SIVsmmPBj 14, Virology, 252, 354-363, 1998.

154. Xu, X.N., Laffert, B., Screaton, G.R., Kraft, M., Wolf, D., Kolanus, W., Mongkolsapay, J., McMichael, A.J., and Baur, A.S., Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor chain, J. Exp. Med., 189, 1489-1496, 1999.

155. Xu, X.N., Screaton, G.R., Gotch, F.M., Dong, T., Tan, R., Almond, N., Walker, B., Stebbings, R., Kent, K., Nagata, S., Stott, J.E., and McMichael, A.J., Evasion of cytotoxic T lymphocyte (CTL) responses by Nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells, J. Exp. Med., 186, 7-16, 1997.

156. Flint, S.J., Principles of Virology: Molecular Biology, Pathogenesis, and Control, ASM Press, Wash­ington, DC, 2000.

157. Gougeon, M.L., Apoptosis as an HIV strategy to escape immune attack, Nat. Rev. Immunol., 3, 392-404, 2003.

158. Hellerstein, M., Hanley, M.B., Cesar, D., Siler, S., Papageorgopoulos, C., Wieder, E., Schmidt, D., Hoh, R., Neese, R., Macallan, D., Deeks, S., and McCune, J.M., Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans, Nat. Med., 5, 83-89, 1999.

159. Lempicki, R.A., Kovacs, J.A., Baseler, M.W., Adelsberger, J.W., Dewar, R.L., Natarajan, V., Bosche, M.C., Metcalf, J.A., Stevens, R.A., Lambert, L.A., Alvord, W.G., Polis, M.A., Davey, R.T., Dimitrov, D.S., and Lane, H.C., Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients, Proc. Natl. Acad. Sci. U.S.A., 97, 13778-13783, 2000.

160. Mohri, H., Perelson, A.S., Tung, K., Ribeiro, R.M., Ramratnam, B., Markowitz, M., Kost, R., Hurley,

A., Weinberger, L., Cesar, D., Hellerstein, M.K., and Ho, D.D., Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy, J. Exp. Med., 194, 1277-1287, 2001.

161. Grossman, Z., Meier-Schellersheim, M., Sousa, A.E., Victorino, R.M., and Paul, W.E., CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause? Nat. Med., 8, 319-323, 2002.

162. Ho, D.D., Neumann, A.U., Perelson, A.S., Chen, W., Leonard, J.M., and Markowitz, M., Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection, Nature, 373, 123-126, 1995.

163. Mohri, H., Bonhoeffer, S., Monard, S., Perelson, A.S., and Ho, D.D., Rapid turnover of T lymphocytes in SIV-infected rhesus macaques, Science, 279, 1223-1227, 1998.

164. Perelson, A.S., Neumann, A.U., Markowitz, M., Leonard, J.M., and Ho, D.D., HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time, Science, 271, 1582-1586, 1996.

165. McCune, J.M., Loftus, R., Schmidt, D.K., Carroll, P., Webster, D., Swor-Yim, L.B., Francis, I.R., Gross,

B. H., and Grant, R.M., High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection, J. Clin. Invest., 101, 2301-2308, 1998.

166. McCune, J.M., Thymic function in HIV-1 disease, Semin. Immunol., 9, 397-404, 1997.

167. Chene, L., Nugeyre, M.T., Guillemard, E., Moulian, N., Barre-Sinoussi, F., and Israel, N., Thy­mocyte-thymic epithelial cell interaction leads to high-level replication of human immunodeficiency virus exclusively in mature CD4(+) CD8(-) CD3(+) thymocytes: a critical role for tumor necrosis factor and interleukin-7, J. Virol., 73, 7533-7542, 1999.

168. Pedroza-Martins, L., Boscardin, W.J., Anisman-Posner, D.J., Schols, D., Bryson, Y.J., and Uitten- bogaart, C.H., Impact of cytokines on replication in the thymus of primary human immunodeficiency virus type 1 isolates from infants, J. Virol., 76, 6929-6943, 2002.

169. Wolf, S.S. and Cohen, A., Expression of cytokines and their receptors by human thymocytes and thymic stromal cells, Immunology, 77, 362-368, 1992.

170. Napolitano, L.A., Grant, R.M., Deeks, S.G., Schmidt, D., De Rosa, S.C., Herzenberg, L.A., Herndier, B.G., Andersson, J., and McCune, J.M., Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis, Nat. Med., 7, 73-79, 2001.

171. Napolitano, L.A., Lo, J.C., Gotway, M.B., Mulligan, K., Barbour, J.D., Schmidt, D., Grant, R.M., Halvorsen, R.A., Schambelan, M., and McCune, J.M., Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone, AIDS, 16, 1103-1111, 2002.

172. Burke, A.P., Anderson, D., Benson, W., Turnicky, R., Mannan, P., Liang, Y.H., Smialek, J., and Virmani, R., Localization of human immunodeficiency virus 1 RNA in thymic tissues from asymptomatic drug addicts, Arch. Pathol. Lab. Med., 119, 36-41, 1995.

173. Joshi, V.V. and Oleske, J.M., Pathologic appraisal of the thymus gland in acquired immunodeficiency syndrome in children. A study of four cases and a review of the literature, Arch. Pathol. Lab. Med., 109, 142-146, 1985.

174. Joshi, V.V., Oleske, J.M., Saad, S., Gadol, C., Connor, E., Bobila, R., and Minnefor, A.B., Thymus biopsy in children with acquired immunodeficiency syndrome, Arch. Pathol. Lab. Med., 110, 837-842, 1986.

175. Prevot, S., Audouin, J., Andre-Bougaran, J., Griffais, R., Le Tourneau, A., Fournier, J.G., and Diebold, J., Thymic pseudotumorous enlargement due to follicular hyperplasia in a human immunodeficiency virus sero-positive patient. Immunohistochemical and molecular biological study of viral infected cells, Am. J. Clin. Pathol., 97, 420-425, 1992.

176. Linder, J., The thymus gland in secondary immunodeficiency, Arch. Pathol. Lab. Med., 111, 1118-1122, 1987.

177. Stanley, S.K., McCune, J.M., Kaneshima, H., Justement, J.S., Sullivan, M., Boone, E., Baseler, M., Adelsberger, J., Bonyhadi, M., Orenstein, J., Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse, J. Exp. Med., 178, 1151-1163, 1993.

178. Aldrovandi, G.M., Feuer, G., Gao, L., Jamieson, B., Kristeva, M., Chen, I.S., and Zack, J.A., The SCID-hu mouse as a model for HIV-1 infection, Nature, 363, 732-736, 1993.

179. Bonyhadi, M.L., Rabin, L., Salimi, S., Brown, D.A., Kosek, J., McCune, J.M., and Kaneshima, H., HIV induces thymus depletion in vivo, Nature, 363, 728-732, 1993.

180. Baskin, G.B., Murphey-Corb, M., Martin, L.N., Davison-Fairburn, B., Hu, F.S., and Kuebler, D., Thymus in simian immunodeficiency virus-infected rhesus monkeys, Lab. Invest., 65, 400-407, 1991.

181. Li, S.L., Kaaya, E.E., Ordonez, C., Ekman, M., Feichtinger, H., Putkonen, P., Bottiger, D., Biberfeld, G., and Biberfeld, P., Thymic immunopathology and progression of SIVsm infection in cynomolgus monkeys, J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 9, 1-10, 1995.

182. Su, L., Kaneshima, H., Bonyhadi, M., Salimi, S., Kraft, D., Rabin, L., and McCune, J.M., HIV-1- induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo, Immunity, 2, 25-36, 1995.

183. Levy, J.A., Pathogenesis of human immunodeficiency virus infection, Microbiol. Rev., 57, 183-289, 1993.

184. Kourtis, A.P., Ibegbu, C., Nahmias, A.J., Lee, F.K., Clark, W.S., Sawyer, M.K., and Nesheim, S., Early progression of disease in HIV-infected infants with thymus dysfunction, N. Engl. J. Med., 335, 1431-1436, 1996.

185. Frederick, T., Mascola, L., Eller, A., O'Neil, L., and Byers, B., Progression of human immunodefi­ciency virus disease among infants and children infected perinatally with human immunodeficiency virus or through neonatal blood transfusion. Los Angeles County Pediatric AIDS Consortium and the Los Angeles County-University of Southern California Medical Center and the University of Southern California School of Medicine, Pediatr. Infect. Dis. J., 13, 1091-1097, 1994.

186. Luzuriaga, K., Wu, H., McManus, M., Britto, P., Borkowsky, W., Burchett, S., Smith, B., Mofenson, L., and Sullivan, J.L., Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants, J. Virol., 73, 362-367, 1999.

187. Douek, D.C., Picker, L.J., and Koup, R.A., T cell dynamics in HIV-1 infection, Annu. Rev. Immunol., 21, 265-304, 2003.

188. Luo, K.X. and Sefton, B.M., Cross-linking of T-cell surface molecules CD4 and CD8 stimulates phosphorylation of the Lck tyrosine protein kinase at the autophosphorylation site, Mol. Cell Biol., 10, 5305-5313, 1990.

189. Oyaizu, N., McCloskey, T.W., Than, S., Hu, R., Kalyanaraman, V.S., and Pahwa, S., Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon- and tumor necrosis factor- secretion, Blood, 84, 2622-2631, 1994.

190. Hashimoto, F., Oyaizu, N., Kalyanaraman, V.S., and Pahwa, S., Modulation of Bcl-2 protein by CD4 cross-linking: a possible mechanism for lymphocyte apoptosis in human immunodeficiency virus infection and for rescue of apoptosis by interleukin-2, Blood, 90, 745-753, 1997.

191. Algeciras, A., Dockrell, D.H., Lynch, D.H., and Paya, C.V., CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis, J. Exp. Med., 187, 711-720, 1998.

192. Nagata, S. and Golstein, P., The Fas death factor, Science, 267, 1449-1456, 1995.

193. Yang, Y. and Ashwell, J.D., Exploiting the apoptotic process for management of HIV: are we there yet? Apoptosis, 6, 139-146, 2001.

194. Berndt, C., Mopps, B., Angermuller, S., Gierschik, P., and Krammer, P.H., CXCR4 and CD4 mediate a rapid CD95-independent cell death in CD4(+) T cells, Proc. Natl. Acad. Sci. U.S.A., 95, 12556-12561, 1998.

195. Jekle, A., Keppler, O.T., De Clercq, E., Schols, D., Weinstein, M., and Goldsmith, M.A., In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4- mediated killing of uninfected CD4 T cells, J. Virol., 77, 5846-5854, 2003.

196. Vlahakis, S.R., Algeciras-Schimnich, A., Bou, G., Heppelmann, C.J., Villasis-Keever, A., Collman, R.C., and Paya, C.V., Chemokine-receptor activation by Env determines the mechanism of death in HIV-infected and uninfected T lymphocytes, J. Clin. Invest., 107, 207-215, 2001.

197. Roumier, T., Castedo, M., Perfettini, J.L., Andreau, K., Metivier, D., Zamzami, N., and Kroemer, G., Mitochondrion-dependent caspase activation by the HIV-1 envelope, Biochem. Pharmacol., 66, 1321-1329, 2003.

198. Castedo, M., Roumier, T., Blanco, J., Ferri, K.F., Barretina, J., Tintignac, L.A., Andreau, K., Perfettini, J.L., Amendola, A., Nardacci, R., Leduc, P., Ingber, D.E., Druillennec, S., Roques, B., Leibovitch, S.A., Vilella-Bach, M., Chen, J., Este, J.A., Modjtahedi, N., Piacentini, M., and Kroemer, G., Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope, EMBO J., 21, 4070-4080, 2002.

199. Castedo, M., Ferri, K.F., Blanco, J., Roumier, T., Larochette, N., Barretina, J., Amendola, A., Nardacci, R., Metivier, D., Este, J.A., Piacentini, M., and Kroemer, G., Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycin∕FKBP12- rapamycin-associated protein-mediated p53 phosphorylation, J. Exp. Med., 194, 1097-1110, 2001.